AGÕæÈ˹ٷ½

STOCK TITAN

[SCHEDULE 13G] Oragenics Inc. SEC Filing

Filing Impact
(Low)
Filing Sentiment
(Neutral)
Form Type
SCHEDULE 13G





Check the appropriate box to designate the rule pursuant to which this Schedule is filed:
Rule 13d-1(b)
Rule 13d-1(c)
Rule 13d-1(d)






SCHEDULE 13G




Comment for Type of Reporting Person: Note to 5, 7, 9 and 11: Based on 822,927 shares outstanding as of June 23, 2025 pursuant to a Form S-1 filed on June 23, 2025 with the Securities and Exchange Commission. Note to 10: The aggregate amount in Row 9 represents the maximum amount of shares that Five Narrow Lane LP can beneficially control under a contractually stipulated 9.99% ownership restriction.


SCHEDULE 13G



Five Narrow Lane LP
Signature:/s/ Arie Rabinowitz
Name/Title:Arie Rabinowitz/Managing Member of the General Partner
Date:07/02/2025
Oragenics

NYSE:OGEN

OGEN Rankings

OGEN Latest News

OGEN Latest SEC Filings

OGEN Stock Data

1.08M
723.29k
12.11%
1.26%
8.27%
Biotechnology
Pharmaceutical Preparations
United States
SARASOTA